A 53-year-old woman was referr ed to us for evaluation of muffled hearing in the right ear th at had progressed gradually over a l-year period. Examination of th e right ear can al revealed that it was obliterated with neurofibromatotic lesions, which filled the meatu s (figure) . Countless neurofibrom atotic lesion s were also seen over th e patient's entire body. She also exhibited scoliosis of th e th or acic spine. Her fam ily histo ry was negative for fibromatosis. Aud iometry revealed a conductive hearin g loss in the right ear th at averaged approximately 45 dB.
The patient was taken to th e operating room , where the lesions were excised and a m eatopl asty was performe d. The pathology examination identified th e patient's condition as cutaneou s neurofibroma. Postop eratively, her hearing returned to normal, and she exhibited no evidence of recurrence during 4 years of follow-up.
Neurofibromatosis type 1,which occurs in 1 of3,000 individuals, is th e result of a genetic defect in chromosome 17. Approxim ately half of all cases are inh erit ed as an autosom al-dom inant patt ern, and th e other half occur as the result of a spo ntaneo us gene mutation. The disease can m an ifest as one of several types of lesions , including cafe au lait spots, cut an eou s tumors, plexiform lesions , axillary freckling, Lisch nodules of the iris, optic gliom as, and bony abnorma lities. Th e National Institutes of Health criteria for th e diagnosis of this disease are very helpful. I Neurofi bro ma tos is typ e 1 can cause conductive hearing loss when it invades th e ear canal as a plexiform lesion in the pr eauricular area. From th ere it can destr oy the bony ear cana l and cart ilage and invade th e middle ear structures.' However, thi s case is different since th e bony ear canal and th e middle ear were intact and the lesion was th e cutaneo us type .
Neurofibromatosis type 1 should be distinguished from neurofibromatosis typ e 2, which is also a genetic disorder with an autosomal-dominant inhe rit ance patt ern . The type 2 variant, in which th e defect is in chromosom e 22, is more rare, occurring in 1 of 50,000 individu als. Hearing loss, if it occurs, is sensorineural. The diagnostic criteria for neur ofibromatosis type 2 are met by an individual who has th e following : (1) bilateral acoustic neuromas, or (2) a first-degree relative with the type 2 disord er and either a uni latera l lesion or two of the followin g: neurofibrom a, me ning iom a, glioma, schwannom a, or juvenile posterior subcapsular lent icular opac ity.
